User profiles for Mark Corkum

Mark T. Corkum, MD, MSc, FRCPC, DRCPSC

Radiation Oncologist, The Ottawa Hospital
Verified email at toh.ca
Cited by 396

Organ at risk dose constraints in SABR: A systematic review of active clinical trials

…, GB Rodrigues, CW Bassim, MT Corkum - Practical radiation …, 2021 - Elsevier
Purpose Organ at risk (OAR) dose constraints are a critical aspect of SABR treatment
planning. There is limited evidence supporting preferred dose constraints for many OARs. We …

[HTML][HTML] Screening for new primary cancers in cancer survivors compared to non-cancer controls: a systematic review and meta-analysis

M Corkum, JA Hayden, G Kephart, R Urquhart… - Journal of Cancer …, 2013 - Springer
Purpose The goal of this study was to synthesize evidence comparing cancer screening
receipt between cancer survivors and non-cancer controls by conducting a systematic review …

[HTML][HTML] A novel salvage option for local failure in prostate cancer, reirradiation using external beam or stereotactic radiation therapy: systematic review and meta …

MT Corkum, LC Mendez, J Chin, D D'Souza… - Advances in radiation …, 2020 - Elsevier
Purpose Reirradiation (re-RT) using external beam radiation therapy (EBRT) is a novel salvage
strategy for local failure in prostate cancer. We performed a systematic review describing …

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: late toxicity and patient reported outcomes from a randomized phase II clinical trial

M Corkum, A Loblaw, Y Hasan, HT Chung… - Radiotherapy and …, 2021 - Elsevier
Background and Purpose Long-term toxicity of high dose-rate brachytherapy as monotherapy
for prostate cancer is not well defined. We report late toxicity and health related quality of …

[HTML][HTML] Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic …

GS Bauman, MT Corkum, H Fakir, TK Nguyen… - BMC cancer, 2021 - Springer
Background Patients with polymetastatic cancer are most often treated with systemic therapy
to improve overall survival and/or delay progression, with palliative radiotherapy reserved …

Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review

M Corkum, R Urquhart, C Kendell, F Burge… - Cancer Causes & …, 2012 - Springer
Purpose Individuals diagnosed with cancer close to death have low access to enrollment in
palliative care programs. The purpose of this literature review was to assess the usefulness …

Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study

MT Corkum, MK Buyyounouski, AJ Chang… - Radiotherapy and …, 2023 - Elsevier
Background and Purpose Local recurrences after previous radiotherapy (RT) are
increasingly being identified in biochemically recurrent prostate cancer. Salvage prostate …

A prospective study of magnetic resonance imaging-guided focal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: Updated results of 30 …

MT Corkum, G Morton, DA Loblaw, CL Tseng… - Practical Radiation …, 2022 - Elsevier
Purpose Limited prospective data on focal salvage high-dose-rate (HDR) prostate
brachytherapy is available. We sought to explore the toxicities, health-related quality of life (HRQoL), …

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in Ontario, Canada

MT Corkum, G Morton, AV Louie, GS Bauman… - Radiotherapy and …, 2020 - Elsevier
Background and purpose Declining prostate brachytherapy utilization has been reported in
several studies, despite strong evidence for efficacy and safety compared to alternatives. We …

[HTML][HTML] Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI

…, H Fakir, G Randhawa, R Alfano, M Corkum… - Clinical and …, 2022 - Elsevier
Purpose Our purpose was to evaluate intra-prostatic cancer volumes for salvage radiotherapy
in men with recurrent prostate cancer confined to the prostate post-primary radiotherapy …